Alice Panchaud

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


170 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2002 |
In press
 
Social determinants of antidepressant continuation during pregnancy in the USA: findings from the ABCD cohort study.
Dupuis M., Weir K.R., Vidonscky Lüthold R., Panchaud A., Baggio S. Archives of women's mental health. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D173C8B9E12F]
 
Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION project.
Melander E., Nielsen E.I., Lindqvist A., Hovd M., Gandia P., Panchaud A., Guidi M., Annaert P., Baranczewski P., Spigset O. et al. Basic & clinical pharmacology & toxicology. Peer-reviewed.
[DOI][Pmid][serval:BIB_A52B902F4CE9]
2024
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Ansermot N., Crettol S., Fischer Fumeaux C.J., Graz M.B., Harari M.M., Weisskopf E., Gandia P. et al., 2024/11. British journal of clinical pharmacology, 90 (11) pp. 2849-2860. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F8B14E5C96]
 
Récepteur Fc néonatal : rôle et ­implications en médecine ­fœto-maternelle [Neonatal Fc receptor : role and implications in maternal fetal medicine]
Maisonneuve É., Panchaud A., Baud D., Gavillet M., 2024/10/16. Revue medicale suisse, 20 (891) pp. 1869-1873. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9D886E90A893]
Drifting Too Far From Shore: Paternal Valproate Statement by the European Medicines Agency (EMA).
Damkier P., Shechtman S., Diav-Citrin O., Panchaud A., Weber-Schoendorfer C., Hodson K., Cleary B., 2024/10. Pharmacoepidemiology and drug safety, 33 (10) pp. e70016. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0966803E124D]
Dispensed drugs during pregnancy in outpatient care between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Marxer C.A., Graber S.M., Surbek D., Panchaud A., Meier C.R., Spoendlin J., 2024/08/12. Swiss medical weekly, 154 p. 3616. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_26DAE3D3AD46]
 
Inhibiting IgG in Hemolytic Disease of the Fetus.
Maisonneuve E., Panchaud A., Baud D., 2024/08/08. The New England journal of medicine, 391 (6) pp. 563-567. Peer-reviewed.
[DOI][Pmid][serval:BIB_71A24FA84E96]
 
Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently Substantiated.
Garey J.D., Damkier P., Scialli A.R., Lusskin S., Braddock S.R., Chouchana L., Cleary B., Conover E.A., Diav-Citrin O., Dragovich R.S. et al., 2024/08. Birth defects research, 116 (8) pp. e2392. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C9C07484EC95]
 
Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy
Graber Michael, Panchaud Alice, Legardeur Helene, Derfuss Tobias, Friedli Christoph, Gobbi Claudio, Zecca Chiara, Granziera Cristina, Jelcic Ilijas, Hammer Helly Noemi et al., 2024/08/01. Clinical and Translational Neuroscience, 8 (3) p. 26.
[DOI][WoS][serval:BIB_E57F4E132D6D]
 
Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®.
Noseda R., Bedussi F., Panchaud A., Ceschi A., 2024/08. Clinical pharmacology and therapeutics, 116 (2) pp. 346-350. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9E296593B70]
Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS).
Srikantha P., Winterfeld U., Girardin F., Panchaud A., Ochsenbein-Kölble N., Simões-Wüst A.P., 2024/07/16. Swiss medical weekly, 154 p. 3751. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1485D89DBE55]
Post-COVID-19 condition: recommendations for pregnant individuals.
Maisonneuve E., Favre G., Boucoiran I., Dashraath P., Panchaud A., Baud D., 2024/05. The Lancet regional health. Europe, 40 p. 100916. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C7FAB58CD09]
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
Dao K., Shechtman S., Weber-Schoendorfer C., Diav-Citrin O., Murad R.H., Berlin M., Hazan A., Richardson J.L., Eleftheriou G., Rousson V. et al., 2024/04/24. BMJ open, 14 (4) pp. e083550. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC208C4ACC61]
 
SSRIs in Pregnancy-What Offspring Brain Volumes Can and Cannot Tell Us.
Ceulemans M., Damkier P., Panchaud A., 2024/03/01. JAMA psychiatry, 81 (3) p. 317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C2FF3C20DE8]
Patisiran exposure in early pregnancy: a case report.
Loser V., Baumgartner T., Legardeur H., Panchaud A., Théaudin M., 2024. Therapeutic advances in neurological disorders, 17 p. 17562864241239755. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_21F888FB9EC0]
Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project.
Nordeng H., Wegler C., Lindqvist A., Melander E., Magnusson M., Gandia P., Panchaud A., Baranczewski P., Spigset O., 2024/01. Basic & clinical pharmacology & toxicology, 134 (1) pp. 153-164. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1D556B094403]
2023
 
Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
Cardoso E., Monfort A., Ferreira E., Fischer Fumeaux C.J., Henriot I., Winterfeld U., Gandia P., Guidi M., Panchaud A., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1940-1947. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_709A7C64E9D4]
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort.
Favre G., Maisonneuve E., Pomar L., Daire C., Monod C., Martinez de Tejada B., Quibel T., Todesco-Bernasconi M., Sentilhes L., Blume C. et al., 2023/10. Clinical microbiology and infection, 29 (10) pp. 1306-1312. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_64F80190B0CC]
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.
Maisonneuve E., de Bruin O., Favre G., Goncé A., Donati S., Engjom H., Hurley E., Al-Fadel N., Siiskonen S., Bloemenkamp K. et al., 2023/07/06. Journal of clinical medicine, 12 (13). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DFB5826426EE]
 
Safety of monoclonal antibodies targeting PCSK9 in pregnancy: Analysis of the WHO's global pharmacovigilance database
Noseda Roberta, Bedussi Francesca, Panchaud Alice, Ceschi Alessandro, 2023/07. Neurotoxicology and Teratology, 98 p. 107242.
[DOI][WoS][serval:BIB_1CF3FD544B0E]
 
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Favre G., Gerbier E., Maisonneuve E., Pomar L., Winterfeld U., Lepigeon K., Bloemenkamp KWM, de Bruin O., Eimir H., Nordeng H. et al., 2023/05. British journal of clinical pharmacology, 89 (5) pp. 1560-1574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0F93E870352]
Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.
Maisonneuve E., Gerbier E., Tauqeer F., Pomar L., Favre G., Winterfeld U., Passier A., Oliver A., Baud D., Nordeng H. et al., 2023/04/29. Viruses, 15 (5) p. 1090. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90BC43AA1255]
Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry.
Favre G., Maisonneuve E., Pomar L., Daire C., Poncelet C., Quibel T., Monod C., Martinez de Tejada B., Schäffer L., Papadia A. et al., 2023/03. The Lancet regional health. Europe, 26 p. 100569. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B8F54B585016]
 
Shall we rethink the timing of epidural anesthesia in anticoagulated obstetrical patients?
Legardeur H., Cuenoud A., Panchaud A., Grandoni F., Mesquita Sauvage A.B., Alberio L., Baud D., Gavillet M., 2023/03. American journal of obstetrics and gynecology, 228 (3) pp. 257-260. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BB1224C9267]
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis.
Smith E.R., Oakley E., Grandner G.W., Rukundo G., Farooq F., Ferguson K., Baumann S., Adams Waldorf K.M., Afshar Y., Ahlberg M. et al., 2023/02. American journal of obstetrics and gynecology, 228 (2) pp. 161-177. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_514F1D71E863]
Mental health of pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European cross-sectional study.
Tauqeer F., Ceulemans M., Gerbier E., Passier A., Oliver A., Foulon V., Panchaud A., Lupattelli A., Nordeng H., 2023/01/11. BMJ open, 13 (1) pp. e063391. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5730356743B1]
Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort.
Gerbier E., Favre G., Maisonneuve E., Ceulemans M., Winterfeld U., Dao K., Schmid CPR, Jenkinson S.P., Niznik B., Baud D. et al., 2023. Journal of diabetes research, 2023 p. 4105993. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8E93F01323A7]
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Fischer Fumeaux C.J., Graz M.B., Morisod Harari M., Weisskopf E., Gandia P., Allegaert K., Nordeng H. et al., 2023. Frontiers in psychiatry, 14 p. 1167870. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE8A9936EA15]
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis.
Abolhassani N., Winterfeld U., Kaplan Y.C., Jaques C., Minder Wyssmann B., Del Giovane C., Panchaud A., 2023/01. BMJ open diabetes research & care, 11 (1) pp. e002919. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09E70EA3988A]
 
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Cardoso E., Monfort A., Ferreira E., Nordeng H., Winterfeld U., Allegaert K., Gandia P., Guidi M., Panchaud A., 2023. Therapie, 78 (2) pp. 149-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_616A71B2E82E]
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy: A Comparative ENTIS Cohort Study.
Dao K., Shechtman S., Diav-Citrin O., George N., Richardson J.L., Rollason V., Pistelli A., Eleftheriou G., Berlin M., Ekobena P. et al., 2023. Journal of clinical psychopharmacology, 43 (1) pp. 12-19. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_009EB5838B3E]
 
Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project.
Cardoso E., Guidi M., Nauwelaerts N., Nordeng H., Teil M., Allegaert K., Smits A., Gandia P., Edginton A., Ito S. et al., 2023. Expert opinion on drug metabolism & toxicology, 19 (5) pp. 269-283. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDFE0C5041A6]
2022
 
The risk of questioning the safety of drugs considered safe in pregnancy at the era of big data: the everlasting case of doxylamine.
Panchaud A., Cleary B., Weber-Schoendorfer C., Shechtman S., Cassina M., Diav-Citrin O., Damkier P., 2022/12. Journal of clinical epidemiology, 152 pp. 125-126. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34E475DA6881]
Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".
Ceulemans M., Sillis L., Foulon V., Panchaud A., Winterfeld U., Pomar L., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/08. Journal of reproductive immunology, 152 p. 103639. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CA029225212]
COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
Favre G., Maisonneuve E., Pomar L., Winterfeld U., Daire C., Martinez de Tejada B., Delecraz D., Campelo S., Moser M., Todesco-Bernasconi M. et al., 2022/07. The Lancet regional health. Europe, 18 p. 100410. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_274FE2B56EDF]
Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational Cross-Sectional Study.
Marxer C.A., Rauch M., Lang C., Panchaud A., Meier C.R., Spoendlin J., 2022/06/28. International journal of environmental research and public health, 19 (13). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4B0FF695AA2]
Queries on medication use during pregnancy: characterisation of the Swiss Teratogen Information Service database.
Baumgartner R., Winterfeld U., Panchaud A., Simões-Wüst A.P., 2022/05/23. Swiss medical weekly, 152 pp. w30187. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C4A0898A24F9]
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D. et al., 2022/04/27. International journal of environmental research and public health, 19 (9) p. 5335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A80E8D0D202]
 
Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy.
Damkier P., Cleary B., Weber-Schoendorfer C., Shechtman S., Cassina M., Panchaud A., Diav-Cirtin O., 2022/03. Nature reviews. Endocrinology, 18 (3) p. 191. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_256D630FA6E8]
Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbek D., Spoendlin J. et al., 2022/01/27. International journal of environmental research and public health, 19 (3) p. 1456. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E15104835DDE]
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2022/01/26. International journal of environmental research and public health, 19 (3) p. 1389. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16ABC557777C]
Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review.
Ngo E., Spigset O., Lupattelli A., Panchaud A., Annaert P., Allegaert K., Nordeng H., 2022/01. Basic & clinical pharmacology & toxicology, 130 (1) pp. 171-181. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_03EE81CDDACC]
Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature.
Diciolla A., Gianoni M., Fleury M., Szturz P., Demartines N., Peters S., Duran R., Desseauve D., Panchaud M.A., Fasquelle F. et al., 2022. Frontiers in oncology, 12 p. 1006387. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83C6E9C8B673]
Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods.
Smith E.R., Oakley E., He S., Zavala R., Ferguson K., Miller L., Grandner G.W., Abejirinde I.O., Afshar Y., Ahmadzia H. et al., 2022. PloS one, 17 (6) pp. e0270150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8799BA87CA14]
Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor.
Balmpouzis Z., Faure van Rossum A., Baud D., Panchaud A., Mitropoulou G., Mazza Stalder J., Koutsokera A., 2022. Respiratory medicine case reports, 40 p. 101776. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40C6261EB44B]
2021
 
A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy.
Marxer C.A., Rüegg S., Rauch M.S., Panchaud A., Meier C.R., Spoendlin J., 2021/12. Expert opinion on drug safety, 20 (12) pp. 1487-1499. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AFE84A1A5F2D]
Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data.
Gerbier E., Graber S.M., Rauch M., Marxer C.A., Meier C.R., Baud D., Winterfeld U., Blozik E., Surbeki D., Spoendlin J. et al., 2021/11/22. Swiss medical weekly, 151 pp. w30048. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DF3C0B2E7521]
Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.
Farhat A., Panchaud A., Al-Hajje A., Lang P.O., Csajka C., 2021/11. European journal of clinical pharmacology, 77 (11) pp. 1747-1756. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1DB8BDAA204]
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic wave.
Lambelet V., Ceulemans M., Nordeng H., Favre G., Horsch A., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/09/13. Swiss medical weekly, 151 pp. w30009. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB7433408976]
Exposure to alirocumab during the first trimester of pregnancy: A case report.
Vuignier Y., Beaud F., Kosinski C., Panchaud A., Lebon S., Baud D., Kissling S., Collet T.H., 2021/09/01. Birth defects research, 113 (15) pp. 1156-1160. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_747A6FD87345]
 
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199".
Stuckelberger S., Favre G., Ceulemans M., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A., Pomar L., 2021/08/05. Viruses, 13 (8) p. 1546. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6DD1C849D220]
 
Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review.
Farhat A., Al-Hajje A., Csajka C., Panchaud A., 2021/08. Journal of clinical pharmacy and therapeutics, 46 (4) pp. 877-886. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E9B3E8C32619]
Maternal outcomes and risk factors for COVID-19 severity among pregnant women.
Vouga M., Favre G., Martinez-Perez O., Pomar L., Acebal L.F., Abascal-Saiz A., Hernandez MRV, Hcini N., Lambert V., Carles G. et al., 2021/07/06. Scientific reports, 11 (1) p. 13898. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8A07BDF1213E]
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional study.
Ceulemans M., Foulon V., Ngo E., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A. et al., 2021/07. Acta obstetricia et gynecologica Scandinavica, 100 (7) pp. 1219-1229. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F78C3540DE58]
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
Stuckelberger S., Favre G., Ceulemans M., Nordeng H., Gerbier E., Lambelet V., Stojanov M., Winterfeld U., Baud D., Panchaud A. et al., 2021/06/22. Viruses, 13 (7) p. 1199. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63F0D5A06B83]
Association between confirmed congenital Zika infection at birth and outcomes up to 3 years of life.
Hcini N., Kugbe Y., Rafalimanana ZHL, Lambert V., Mathieu M., Carles G., Baud D., Panchaud A., Pomar L., 2021/06/01. Nature communications, 12 (1) p. 3270. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB927AF20678]
 
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION project.
Nauwelaerts N., Deferm N., Smits A., Bernardini C., Lammens B., Gandia P., Panchaud A., Nordeng H., Bacci M.L., Forni M. et al., 2021/04. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 136 p. 111038. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5C9C5C8AE4E0]
Vaccine Willingness and Impact of the COVID-19 Pandemic on Women's Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic.
Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O'Shaughnessy F., Passier A., Richardson J.L. et al., 2021/03/24. International journal of environmental research and public health, 18 (7) p. 3367. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9183E2F6389C]
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2D36E32A728F]
Maternal Infection and Adverse Pregnancy Outcomes among Pregnant Travellers: Results of the International Zika Virus in Pregnancy Registry.
Vouga M., Pomar L., Soriano-Arandes A., Rodó C., Goncé A., Gratacos E., Merriam A., Eperon I., Martinez De Tejada B., Eggel B. et al., 2021/02/22. Viruses, 13 (2) p. 341. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A716B11D8E92]
Valproate in pregnancy: authors' reply.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Ruegg S., Meier C., Winterfeld U., Panchaud A., 2021/02/15. Swiss medical weekly, 151 pp. w20481. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_67F3648F32BF]
Prolonged Maternal Zika Viremia as a Marker of Adverse Perinatal Outcomes.
Pomar L., Lambert V., Matheus S., Pomar C., Hcini N., Carles G., Rousset D., Vouga M., Panchaud A., Baud D., 2021/02. Emerging infectious diseases, 27 (2) pp. 490-498. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1464F23F2CD5]
Impact of Pharmaceutical Interventions in Hospitalized Patients: A Comparative Study Between Clinical Pharmacists and an Explicit Criteria-Based Tool.
Farhat A., Abou-Karroum R., Panchaud A., Csajka C., Al-Hajje A., 2021. Current therapeutic research, clinical and experimental, 95 p. 100650. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_468B1ED3F169]
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Spoendlin J., Blozik E., Graber S., Rauch M., Marxer C., Rüegg S., Meier C., Winterfeld U., Panchaud A., 2021/01/01. Swiss medical weekly, 151 pp. w20386. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5BAD5FF48EFC]
2020
SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care.
Lambelet V., Vouga M., Pomar L., Favre G., Gerbier E., Panchaud A., Baud D., 2020/12. Prenatal diagnosis, 40 (13) pp. 1641-1654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BA01F2C7D1AF]
 
Placental infection by Zika virus in French Guiana.
Pomar L., Lambert V., Madec Y., Vouga M., Pomar C., Matheus S., Fontanet A., Panchaud A., Carles G., Baud D., 2020/11. Ultrasound in obstetrics & gynecology, 56 (5) pp. 740-748. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EF761D62BBF9]
Vertical transmission and materno-fetal outcomes in 13 patients with coronavirus disease 2019.
Masmejan S., Pomar L., Favre G., Panchaud A., Giannoni E., Greub G., Baud D., 2020/11. Clinical microbiology and infection, 26 (11) pp. 1585-1587. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96AF31F294C4]
Zika Virus.
Masmejan S., Musso D., Vouga M., Pomar L., Dashraath P., Stojanov M., Panchaud A., Baud D., 2020/10/28. Pathogens, 9 (11) pp. E898. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A1E0AA0786FD]
Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study.
Bruggmann C., Fournier S., Panchaud A., Muller O., Sadeghipour F., Voirol P., 2020/08/10. Swiss medical weekly, 150 pp. w20321. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_679D016A7A28]
 
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.
Weisskopf E., Guidi M., Fischer C.J., Bickle Graz M., Beaufils E., Nguyen K.A., Morisod Harari M., Rouiller S., Rothenburger S., Gaucherand P. et al., 2020/08. British journal of clinical pharmacology, 86 (8) pp. 1642-1653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6EA0D4637119]
 
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
Martínez-Perez O., Vouga M., Cruz Melguizo S., Forcen Acebal L., Panchaud A., Muñoz-Chápuli M., Baud D., 2020/07/21. JAMA, 324 (3) pp. 296-299. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0285A657B48F]
 
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Gavillet M., Rolnik D.L., Hoffman M.K., Panchaud A., Baud D., 2020/06. Ultrasound in obstetrics & gynecology, 55 (6) pp. 843-844. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E01854BB92B7]
 
Tachysystole and risk of cesarean section after labor induction using misoprostol: A cohort study.
Sichitiu J., Vial Y., Panchaud A., Baud D., Desseauve D., 2020/06. European journal of obstetrics, gynecology, and reproductive biology, 249 pp. 54-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7AA115EF3838]
An international registry for emergent pathogens and pregnancy.
Panchaud A., Favre G., Pomar L., Vouga M., Aebi-Popp K., Baud D., COVI-Preg group, 2020/05/09. Lancet, 395 (10235) pp. 1483-1484. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D6D3BAE067B1]
2019
 
A critical analysis of the neurodevelopmental and neurosensory outcomes after 2 years for children with in utero Zika virus exposure.
Vouga M., Pomar L., Panchaud A., Musso D., Baud D., 2019/11. Nature medicine, 25 (11) pp. 1641-1642. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B451F39E1658]
 
Gestion du traitement de l’asthme chez une femme enceinte
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
[serval:BIB_01CC04D18510]
 
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update.
Fischer Fumeaux C.J., Morisod Harari M., Weisskopf E., Eap C.B., Epiney M., Vial Y., Csajka C., Bickle Graz M., Panchaud A., 2019/10. Expert opinion on drug safety, 18 (10) pp. 949-963. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AACEB7EFC408]
 
Therapiemanagement von Asthma bei einer schwangeren Frau
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
[serval:BIB_45CF28833B1E]
 
Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald S.C., Cohen J.M., Panchaud A., McElrath T.F., Huybrechts K.F., Hernández-Díaz S., 2019/09. Pharmacoepidemiology and drug safety, 28 (9) pp. 1211-1221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0767DAE9297F]
 
Safety of medication use during pregnancy and breastfeeding
Panchaud A., Di Paolo E.R., 2019/05/20. pp. 1-16 dans Swiss recommendations for adult cystic fibrosis care chap. 13, Revue Médicale Suisse, Koutsokera A, Sauty A, et al..
[serval:BIB_5956240E9744]
 
Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome.
Pomar L., Musso D., Malinger G., Vouga M., Panchaud A., Baud D., 2019/05. Prenatal diagnosis, 39 (6) pp. 420-430. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E41E82C3F73]
2018
Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana.
Pomar L., Vouga M., Lambert V., Pomar C., Hcini N., Jolivet A., Benoist G., Rousset D., Matheus S., Malinger G. et al., 2018/10/31. BMJ, 363 pp. k4431. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AAEDED9EBA44]
 
Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study.
Panchaud A., Cohen J.M., Patorno E., Huybrechts K.F., Desai R.J., Gray K.J., Mogun H., Hernandez-Diaz S., Bateman B.T., 2018/08/07. Neurology, 91 (6) pp. e533-e542. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8E4DE1A64D9]
 
Zika virus, vaccines, and antiviral strategies.
Masmejan S., Baud D., Musso D., Panchaud A., 2018/06. Expert review of anti-infective therapy, 16 (6) pp. 471-483. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B9120567621]
 
Infant Exposure to Methylphenidate and Duloxetine During Lactation.
Collin-Lévesque L., El-Ghaddaf Y., Genest M., Jutras M., Leclair G., Weisskopf E., Panchaud A., Ferreira E., 2018/04. Breastfeeding medicine, 13 (3) pp. 221-225. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F27DF0DA953]
 
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.
Panchaud A., Rousson V., Vial T., Bernard N., Baud D., Amar E., De Santis M., Pistelli A., Dautriche A., Beau-Salinas F. et al., 2018/03. British journal of clinical pharmacology, 84 (3) pp. 568-578. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B81A0F10409F]
 
Médicaments, grossesse et allaitement
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2018. dans BabyGuide – Le Manuel officiel Suisse , Editions BabyGuide Sàrl.
[serval:BIB_79A1BBE5EC46]
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.
Lupattelli A., Twigg M.J., Zagorodnikova K., Moretti M.E., Drozd M., Panchaud A., Rieutord A., Juraski R.G., Odalovic M., Kennedy D. et al., 2018. Clinical epidemiology, 10 pp. 655-669. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_780277B3ADA4]
2017
 
Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
Panchaud A., Hernandez-Diaz S., Freeman M.P., Viguera A.C., MacDonald S.C., Sosinsky A.Z., Cohen L.S., 2017/12. Journal of psychiatric research, 95 pp. 84-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4A142CFF44F]
 
Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry.
Weisskopf E., Panchaud A., Nguyen K.A., Grosjean D., Hascoët J.M., Csajka C., Eap C.B., Ansermot N., collaborators of the SSRI-Breast Milk study, 2017/07/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1057 pp. 101-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA86621FAFDC]
 
Pregabalin use early in pregnancy and the risk of major congenital malformations.
Patorno E., Bateman B.T., Huybrechts K.F., MacDonald S.C., Cohen J.M., Desai R.J., Panchaud A., Mogun H., Pennell P.B., Hernandez-Diaz S., 2017/05/23. Neurology, 88 (21) pp. 2020-2025. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F75F0FC5F5E2]
 
Zika virus: are we going too far?
Vouga M., Musso D., Schaub B., Panchaud A., Baud D., 2017/01/14. Lancet (London, England), 389 (10065) p. 151. Peer-reviewed.
[DOI][Pmid][serval:BIB_235AB150E4B3]
2016
 
Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry.
Weisskopf E., Panchaud A., Nguyen K.A., Grosjean D., Hascoët J.M., Csajka C., Eap C.B., Ansermot N., collaborators of the SSRI-Breast Milk study, 2016/11/30. Journal of pharmaceutical and biomedical analysis, 131 pp. 233-245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B83BFE02B0D1]
 
An international registry for women exposed to Zika virus during pregnancy: time for answers.
Panchaud A., Vouga M., Musso D., Baud D., 2016/09. The Lancet. Infectious diseases, 16 (9) pp. 995-996. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_885EFAA12E5C]
 
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Huybrechts K.F., Hernández-Díaz S., Patorno E., Desai R.J., Mogun H., Dejene S.Z., Cohen J.M., Panchaud A., Cohen L., Bateman B.T., 2016/09/01. JAMA psychiatry, 73 (9) pp. 938-946. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_07388D5073F1]
 
Clinical management of pregnant women exposed to Zika virus.
Vouga M., Musso D., Panchaud A., Baud D., 2016/07. The Lancet. Infectious diseases, 16 (7) p. 773. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_980F74A12192]
 
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
Barceló C., Gaspar F., Aouri M., Panchaud A., Rotger M., Guidi M., Cavassini M., Buclin T., Decosterd L.A., Csajka C. et al., 2016/07. The Journal of antimicrobial chemotherapy, 71 (7) pp. 1933-1942. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_001364580150]
 
Pregnancy outcome following maternal exposure to pregabalin may call for concern.
Winterfeld U., Merlob P., Baud D., Rousson V., Panchaud A., Rothuizen L.E., Bernard N., Vial T., Yates L.M., Pistelli A. et al., 2016/06/14. Neurology, 86 (24) pp. 2251-2257. Peer-reviewed.
[DOI][Pmid][serval:BIB_BAB64140AB78]
 
Clinical management of pregnant women exposed to Zika virus.
Baud D., Van Mieghem T., Musso D., Truttmann A.C., Panchaud A., Vouga M., 2016/05. The Lancet. Infectious diseases, 16 (5) p. 523. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECC49714CCB6]
 
Harness shared data in international Zika registry.
Baud D., Gérardin P., Merriam A., Alves M.P., Musso D., Genton B., Panchaud A., 2016/04/05. BMJ (Clinical research ed.), 355 pp. i5319. Peer-reviewed.
[Pmid][serval:BIB_BFA1C6A5B1E5]
 
Outbreak in meldonium positive laboratory tests: are we missing something?
Panchaud A., Csajka C., 2016/04. British journal of sports medicine, 50 (22) pp. 1422-1423. Peer-reviewed.
[DOI][Pmid][serval:BIB_34C01DC804AD]
Bon usage des antidépresseurs ISRS durant la grossesse--le défi de l'évaluation de la balance bénéfice-risque [SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio].
Weisskopf E., Fumeaux C.J., Bickle Graz M., Harari M.M., Epiney M., Tolsa C.B., Rouiller S., Tolsa J.F., Eap C.B., Vial Y. et al., 2016. Revue Médicale Suisse, 12 (510) pp. 561-566. Peer-reviewed.
[URN][Pmid][serval:BIB_C18A424B9682]
 
Cas clinique n°5 - fibrillation auriculaire.
Guignard B., Beney Johnny, Panchaud Alice, Csajka Chantal, Meyer Philippe, 2016. pharmaJournal 07 pp. 5-9.
[serval:BIB_7A85BB8F0F8F]
 
Dispelling the "nice or naughty myth" with ecological fallacy.
Hoarau G., Panchaud A., Spodenkiewicz M., Baud D., Gérardin P., 2016. BMJ online p. 1.
[serval:BIB_67B43AAECC92]
 
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes.
Panchaud A., Stojanov M., Ammerdorffer A., Vouga M., Baud D., 2016. Clinical Microbiology Reviews, 29 (3) pp. 659-694. Peer-reviewed.
[DOI][Pmid][serval:BIB_327A8827A086]
 
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C., 2016. Respiration; international review of thoracic diseases, 91 (4) pp. 333-348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8F67FDB86FD]
Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting.
Corbel A., Baud D., Chaouch A., Beney J., Csajka C., Panchaud A., 2016. Plos One, 11 (3) pp. e0151205. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A5136B4D227F]
2015
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
[URN][DOI][serval:BIB_848AD57B1B48]
 
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.
Guidi M., Foletti G., McLaren P., Cavassini M., Rauch A., Tarr P.E., Lamy O., Panchaud A., Telenti A., Csajka C. et al., 2015/07. Antiviral Therapy, 20 (3) pp. 261-269. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60B0877DA09D]
 
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E. et al., 2015/06. Journal of Clinical Psychopharmacology, 35 (3) pp. 250-259. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C8D9F29667C]
 
Patterns and factors associated with low adherence to psychotropic medications during pregnancy-a cross-sectional, multinational web-based study.
Lupattelli A., Spigset O., Björnsdóttir I., Hämeen-Anttila K., Mårdby A.C., Panchaud A., Juraski R.G., Rudolf G., Odalovic M., Drozd M. et al., 2015/02. Depression and Anxiety, 32 (6) pp. 426-436. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0731FCAB51B9]
 
Cas clinique n°4 - prescription inappropriée chez le patient âgé: entre trop et trop peu de médicaments.
Csajka Chantal, Panchaud Alice, Guignard Bertrand, Beney Johnny, Spinewine Anne, 2015. pharmaJournal 7 pp. 5-7.
[serval:BIB_D551A62AEEBB]
 
Grossesse, naissance et les trois premières années de l’enfant
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2015. dans BabyGuide – Le Manuel officiel Suisse, BabyGuide.
[serval:BIB_3F02A6AA5680]
 
Médicaments, grossesse et lactation.
Delaloye J.F., Panchaud A., Weisskopf E., Winterfeld U., Rothuizen L., Vial Y., Csajka C., Buclin T., Hohlfeld P., 2015/01., 4e éd. 252 p, Médecine et Hygiène.
[serval:BIB_267D2934EC39]
 
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.
Weisskopf E., Fischer C.J., Bickle Graz M., Morisod Harari M., Tolsa J.F., Claris O., Vial Y., Eap C.B., Csajka C., Panchaud A., 2015. Expert Opinion On Drug Safety, 14 (3) pp. 413-427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A6E08AD4EF04]
2014
 
Le paracétamol reste l'antalgique de 1er choix pendant la grossesse
Panchaud A, Baud D, 2014/12. PharmaJournal 7-8 pp. 7-8.
[URN][serval:BIB_3C8EB73D22AB]
 
Cas clinique n° 3 : médicaments et rein
Beney J., Panchaud A., Guignard B., Csajka C., 2014/10. PharmaJournal 21 pp. 5-7.
[URN][serval:BIB_4F2A78DC1AF4]
 
Cas clinique n°2: épilepsie et grossesse.
Panchaud A., Guignard B., Beney J., Baud D., Csajka C., Ferreira E., 2014/06. pharmaJournal, 12 (6) pp. 5-7.
[serval:BIB_68F07874517B]
 
Cas clinique n°1 : Insuffisance cardiaque
Guignard B, Beney J, Panchaud A, Csajka C, De Denus S, 2014/03. PharmaJournal, 7 (3) pp. 5-8.
[URN][serval:BIB_82673EAA3BE1]
 
Medication use in pregnancy: a cross-sectional, multinational web-based study.
Lupattelli A., Spigset O., Twigg M.J., Zagorodnikova K., Mårdby A.C., Moretti M.E., Drozd M., Panchaud A., Hämeen-Anttila K., Rieutord A. et al., 2014/02. Bmj Open, 4 (2) pp. e004365.
[URN][DOI][WoS][Pmid][serval:BIB_AEA5D76112F5]
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_72BDC14B7721]
 
Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique [Pharmacokinetic Alterations in Pregnancy and Use of Therapeutic Drug Monitoring].
Panchaud A., Weisskopf E., Winterfeld U., Baud D., Guidi M., Eap C.B., Csajka C., Widmer N., 2014. Therapie, 69 (3) pp. 223-234. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_18592A49D874]
 
Médicaments, grossesse et allaitement
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2014. pp. 23-25 dans BabyGuide – Le Manuel officiel Suisse, BabyGuide.
[serval:BIB_B3E8A046842B]
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
Arab-Alameddine M., Lubomirov R., Fayet-Mello A., Aouri M., Rotger M., Buclin T., Widmer N., Gatri M., Ledergerber B., Rentsch K. et al., 2014. Journal of Antimicrobial Chemotherapy, 69 (9) pp. 2489-2498. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1E8FAB4C9089]
 
Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey.
Csajka C., Jaquet A., Winterfeld U., Meyer Y., Einarson A., Panchaud A., 2014. Swiss Medical Weekly, 144 pp. w13936.
[URN][DOI][WoS][Pmid][serval:BIB_AF074CA6B747]
2013
 
Antidépresseurs, grossesse et allaitement : une étude multicentrique
Weisskopf E., Lepigeon K., Fischer C., Morisod M., Bickle M., Eap C.B., Tolsa J-F., Vial Y., Csajka C., Panchaud A., 2013. Forum Gynécologie Suisse, 13 (2) pp. 4-6.
[serval:BIB_73EE20F9060C]
 
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (11) p. 1440.
[DOI][WoS][Pmid][serval:BIB_ECF16CE99D2A]
 
Certificat de formation continue en Pharmacie clinique: une nouvelle opportunité de formation.
Panchaud A., Csajka C., 2013. PharmaJournal, 12 (6) pp. 17-18.
[serval:BIB_A9655AD8E1DC]
 
Etude multicentrique: antidépresseurs, grossesse et allaitement.
Weisskopf E., Lepigeon K., Fischer C., Morisod M., Bickle M., Eap C.B., Tolsa J.F., Vial Y., Csajka C., Panchaud A., 2013. Forum Gynécologie Suisse, 13 (2) pp. 4-6.
[serval:BIB_05F36D52BCB4]
 
Medikamente, Schwangerschaft und Stillzeit: nicht alle Informationsquellen sind verlässlich
Panchaud A., Berger J., Csajka C., Bugnon O., 2013. PharmaJournal, 151 (1) pp. 16-17.
[serval:BIB_14CEBB66AEE6]
 
Médicaments tocolytiques: utilisation en cas de menace d'accouchement prématuré.
Weisskopf E., Lepigeon K., Baud D., Csajka C., Panchaud A., 2013. PharmaJournal, 19 (9) pp. 5-7.
[serval:BIB_6DCBA3059E7C]
 
Médicaments, grossesse et allaitement.
Panchaud Alice, Berger Jérôme, Bugnon Olivier, 2013. BabyGuide - le manuel officiel suisse pp. 31-33.
[serval:BIB_E3F0E72736C3]
 
Médicaments, grossesse et allaitement: toutes les sources d'information ne sont pas fiables!
Panchaud A., Berger J., Csajka C., Bugnon O., 2013. PharmaJournal, 151 (1) pp. 15-16.
[serval:BIB_C0B2106033EA]
Pregnancy outcome following maternal exposure to Mirtazapine: Preliminary results of a collaborative ENTIS study.
Winterfeld U., Buclin T., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., te Winkel B., Clementi M., Pistelli A. et al., 2013. pp. e1-e2 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
[URN][serval:BIB_26030447190E]
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76900E4385FF]
2012
 
Bedeutet eine radiologische Untersuchung immer eine Gefahr für das ungeborene Kind?
Panchaud A., Verdun F.R., Csajka C., 2012. PharmaJournal, 150 (17) pp. 8-11.
[serval:BIB_57D324A36CF8]
 
Management of deficient lactation in Switzerland and Canada: a survey of midwives' current practices.
Winterfeld U., Meyer Y., Panchaud A., Einarson A., 2012. Breastfeeding Medicine, 7 pp. 317-318.
[DOI][WoS][Pmid][serval:BIB_204FB7BDDD19]
 
Médicaments, grossesse et allaitement
Panchaud A., Berger J., Bugnon O., 2012. pp. 31-33 dans BabyGuide, Editions BabyGuide Sàrl.
[serval:BIB_0AE662C12EF6]
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A2D63B38436E]
 
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Klieger-Grossmann C., Weitzner B., Panchaud A., Pistelli A., Einarson T., Koren G., Einarson A., 2012. Journal of Clinical Pharmacology, 52 (5) pp. 766-770. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_545BDA01DAD7]
 
Preliminary results of venlafaxine exposure in pregnancy, a multicenter prospective cohort ENTIS study
Te Winkel B.A., Beghin D., Pistelli A., Carusod A., Cassina M., Lorenzi F., Malm H.T., Panchaud A., Stahl B., 2012. pp. 171-172 dans 40th Annual Conference of the European Teratology Society, Reproductive Toxicology. Peer-reviewed.
[serval:BIB_B56C8580124B]
 
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.
Einarson A., Smart K., Vial T., Diav-Citrin O., Yates L., Stephens S., Pistelli A., Kennedy D., Taylor T., Panchaud A. et al., 2012. Journal of Clinical Psychiatry, 73 (11) p. 1471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E250A4CC1FB6]
 
Un examen radiologique est-il toujours à risque pour l'enfant à naître?
Panchaud A., Verdun F. R., Csajka C., 2012. PharmaJournal, 150 (17) pp. 5-8.
[serval:BIB_41F7C08AD1D4]
2011
 
Evaluation of risk perception related to drug use during pregnancy: a Swiss survey
Jaquet A., Winterfeld U., Meyer Y., Buclin T., Csajka C., Panchaud A., 2011. pp. 422-423 dans 39th ESCP European Symposium on Clinical Pharmacy and 13th SFPC Congress: Clinical Pharmacy at the Front Line of Innovations, International Journal of Clinical Pharmacy. Peer-reviewed.
[WoS][serval:BIB_9D071EE1F834]
 
Prediction of Infant Drug Exposure Through Breastfeeding: Population PK Modeling and Simulation of Fluoxetine Exposure.
Panchaud A., Garcia-Bournissen F., Csajka C., Kristensen J.H., Taddio A., Ilett K.F., Begg E.J., Ito S., 2011. Clinical Pharmacology and Therapeutics, 89 (6) pp. 830-836. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A212696EF074]
 
Pregnancy outcome following maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 32 dans 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, British Journal of Clinical Pharmacology. Peer-reviewed.
[WoS][serval:BIB_356C95ABEEAB]
 
Pregnancy Outcome Following Maternal Exposure To Statins: A Multicenter Prospective Study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 142 dans 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Basic & Clinical Pharmacology & Toxicology. Peer-reviewed.
[WoS][serval:BIB_097345A56E49]
2010
Anwendung von Galaktogoga in der Schweiz
Meyer Y., Winterfeld U., Panchaud A., 2010. Hebamme.ch = Sage-femme.ch 5 pp. 4-9. Peer-reviewed.
[URN][serval:BIB_9C6BC5A01BBA]
 
Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis.
Garcia-Bournissen F., Altcheh J., Panchaud A., Ito S., 2010. Archives of Disease In Childhood, 95 (3) pp. 224-228.
[DOI][WoS][Pmid][serval:BIB_D46D8B66ABD6]
 
Population PK-guided simulation study in children exposed to drugs in human milk
Ito S., Garcia-Bournissen F., Panchaud A., Csajka C., Kristensen J., Taddio A., Ilett K., Begg E., Tomlinson G., 2010. p. 40 dans 16th World Congress of Basic and Clinical Pharmacology, Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.
[serval:BIB_625295E90C95]
 
Pregnancy outcome after maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A., Berlin M. et al., 2010. dans 21st Annual Meeting of the European Network Teratogen Information Services (ENTIS).
[serval:BIB_A6F9F6CDE49A]
2009
 
Codeine and breastfeeding: cases and STIS position
Panchaud A., Buclin T., 2009. dans 2nd Annual Meeting of the Swiss Association for Perinatal Pharmacology.
[serval:BIB_3C6F9292E4C4]
 
Exposition du nourrisson aux médicaments à travers le lait maternel : évaluation du degré d'exposition
Panchaud Alice, Csajka Chantal, 2009. Pharmajournal, 147 (9) p. 15.
[serval:BIB_22B2B640C8D3]
 
Le swissYPG se présente [Die swissYPG stellt sich vor]
Widmer N., Locca J.-F., Krähenbühl J.-M., Panchaud Monnat A., Grossenbacher-Flückiger C., 2009. GSASA Journal, 23 (3) pp. 71-72.
[serval:BIB_601689A1023C]
 
Pratique en cas de lactogénèse insuffisante
Meyer Yvonne, Winterfeld Ursula, Panchaud Alice, 2009. Hebamme.ch = Sage-femme.ch, 2009 (10) pp. 40-45.
[serval:BIB_1FFC319EA852]
 
Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine
Garcia-Bournissen F., Panchaud A., Csajka C., Kristensen J.H.., Taddio A, Ilett K.F., Begg E.J., Ito S., 2009. pp. S1 dans 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Clinical Pharmacology and Therapeutics. Peer-reviewed.
[WoS][serval:BIB_6443F343035E]
2008
 
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
Einarson A., Pistelli A., DeSantis M., Malm H., Paulus W.D., Panchaud Alice, Kennedy D., Einarson T.R., Koren G., 2008. American Journal of Psychiatry, 165 (6) pp. 749-752.
[DOI][WoS][Pmid][serval:BIB_4BDEFA7B9E4D]
 
Les risques liés à l'utilisation des rétinoïdes topiques pendant la grossesse
Panchaud A., Stah B., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G., Rothuizen L.E. et al., 2008. Tribune médicale = Medical Tribune, 14 (Mai 21-22) p. 11.
[serval:BIB_7CB319A8DBDE]
 
Médicaments et allaitement: quelques éléments à considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale suisse, 4 (146) pp. 540-545.
[Pmid][serval:BIB_D2B0759CD078]
 
Organisation des Datenfassung und Empfehlung beim STIS
Panchaud A., 2008. dans 1st Annual Meeting of the Swiss Association of Perinatal Pharmacology.
[serval:BIB_456841394D48]
 
Should paroxetine be used to treat depression during pregnancy? [author reply]
Einarson A., Pistelli A., DeSantis M., Malm H., Paulus W.D., Panchaud A., Kennedy D., Einarson T.R., Koren G., 2008. American Journal of Psychiatry, 165 (11) pp. 1487-1488.
[DOI][serval:BIB_83CC09EC9BD5]
 
Topical retinoids exposure during pregnancy.
Panchaud A., Stahl B., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G., Buclin T., 2008. pp. e677-e678 dans 9th World Conference on Clinical Pharmacology and Therapeutics, Canadian Journal of Clinical Pharmacology.
[serval:BIB_7618155BC355]
2007
 
Paroxetine use in pregnancy and cardiovascular defects
Einarson A., Pistelli A., DeSantis M., Chambers C., Malm H., Paulus W., Panchaud A., Kennedy D., Einarson T., Koren G., 2007. pp. S130 dans 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Pharmacoepidemiology and Drug Safety. Peer-reviewed.
[WoS][serval:BIB_F047D070935A]
2006
 
Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.
Panchaud A., Sauty A., Kernen Y., Decosterd L.A., Buclin T., Boulat O., Hug C., Pilet M., Roulet M., 2006/06. Clinical Nutrition, 25 (3) pp. 418-427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E4584C2980DA]
 
Attitude de prescription chez la femme enceinte : exemple de prise en charge d'un état dépressif
Panchaud A., Rothuizen L.E., Buclin T., 2006. Swiss Medical Forum = Forum Médical Suisse, 6 (43) pp. 961-964. Peer-reviewed.
[serval:BIB_F9F8EB1B65FD]
 
Malformations cardiaques congénitales sous paroxétine
Panchaud A., Rothuizen L.E., Buclin T., 2006. Journal Suisse de Pharmacie, 144 (8) pp. 292-295.
[serval:BIB_F6F973A994E2]
 
Place des apports oraux en acides gras oméga-3 dans la mucoviscidose [Relevance of omega-3 fatty acid oral supplementation in cystic fibrosis]
Panchaud A., Kernen Y., Roulet M., 2006. Nutrition Clinique et Métabolisme, 20 (1) pp. 41-47. Peer-reviewed.
[DOI][serval:BIB_C0CB2D7F7B43]
2005
 
A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes
Panchaud A., Avois L., Roulet M., Pilet M., Hug C., Saugy M., Decosterd L. A., 2005/06. Analytical Biochemistry, 341 (1) pp. 58-68.
[DOI][WoS][Pmid][serval:BIB_D4BD57B87E02]
 
Dietary supplementation with omega-3 in cystic fibrosis patients
Panchaud A., Sauty A., Kernen Y., Decosterd L.A., Buclin T., Hug C., Pilet M., Roulet M., 2005. pp. S88 dans 28th European Cystic Fibrosis Conference, Journal of Cystic Fibrosis. Peer-reviewed.
[serval:BIB_685CFB9F9BDB]
2002
 
Optimisation des apports oraux chez des patients mucoviscidosiques: place des acides gras oméga-3
Panchaud A., Roulet M., 2002. dans 4es Journées Francophones de Nutrition. Peer-reviewed.
[serval:BIB_CA399B6EF9B6]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University